Literature DB >> 8121238

Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits.

X J Yu1, Y J Li, Y Xiong.   

Abstract

In the present study, the concentration of NG,NG-dimethylarginine (DMA), an endogenous inhibitor of nitric oxide synthesis, was measured with high-performance liquid chromatography, and the effect of hypercholesterolemia on DMA level was investigated in the high fat, high cholesterol fed rabbit. After 6 weeks on a high fat, high cholesterol diet, serum total cholesterol, triglycerides, and lipid peroxides were increased, and atherosclerosis was shown by means of morphological examination. In these rabbits with atherosclerosis, serum level of DMA was significantly raised, while serum creatine level remained normal. This study suggests that chronic hypercholesteremia may stimulate DMA production through elevation of lipid peroxides. The present results implicate endogenous DMA as a contributor to the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8121238     DOI: 10.1016/0024-3205(94)00443-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

Review 1.  Nitric oxide in the human cardiovascular system--SKB lecture 1997.

Authors:  P Vallance
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

2.  Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases.

Authors:  J M Leiper; J Santa Maria; A Chubb; R J MacAllister; I G Charles; G S Whitley; P Vallance
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

3.  Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings.

Authors:  L Fontana; K L McNeill; J M Ritter; P J Chowienczyk
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase.

Authors:  R J MacAllister; H Parry; M Kimoto; T Ogawa; R J Russell; H Hodson; G S Whitley; P Vallance
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

5.  Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.

Authors:  Jun-Lin Jiang; Nian-sheng Li Ns; Yuan-Jian Li; Han-Wu Deng
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 6.  Atherogenesis and the arginine hypothesis.

Authors:  J P Cooke; R K Oka
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

7.  Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine.

Authors:  De-Jian Jiang; Jun-Lin Jiang; Gui-Shan Tan; Yan-Hua Du; Kang-Ping Xu; Yuan-Jian Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-15       Impact factor: 3.000

Review 8.  Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis.

Authors:  Maurício Batista Paes Landim; Antônio Casella Filho; Antônio Carlos Palandri Chagas
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

9.  Nitric oxide function in atherosclerosis.

Authors:  K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

10.  High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats.

Authors:  M B P Landim; P M M Dourado; A Casella-Filho; A C P Chagas; P L da-Luz
Journal:  Braz J Med Biol Res       Date:  2013-05-10       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.